According to FutureWise analysis the market for dry age-related macular degeneration in 2023 is US$ 1.63 billion, and is expected to reach US$ 3.2 billion by 2031 at a CAGR of 8.80%.
Global, age-related macular degeneration is the leading cause of severe visual impairment and disability in older adults. This review focuses on current trends in the development of new therapies targeting specific pathophysiological pathways in dry aged-related macular degeneration. It is expected that improving our understanding of the complex mechanisms of dry aged-related macular degeneration will help to address this largely unmet clinical need. The development of the global dry Age-related Macular Degeneration market is attributed to the growth of geriatric populations and their growing prevalence of age-related macular degeneration, as well as the development of new treatment techniques for dry Age-related macular degeneration combined with the increasing number of clinical trials for dry age-related macular degeneration. Variables like expanding medical services use will probably aid the market's development. Growing geriatric populations and the rise in dry age-related macular degeneration are driving the global market expansion.
The disease progresses gradually to cause severe vision loss in the central vision. Early signs of age-related macular degeneration, specifically age-related maculopathy, include extracellular deposits, subretinal deposits of oxidized lipids and proteins beneath the retinal pigment epithelium, and variable quantities of visible clumps of pigment in the macula. During the intermediate stages of age-related macular degeneration(AMD), drusen become larger and pigmentary changes become more severe. As AMD progresses, patients develop either subretinal choroidal neovascularization or non-neovascular "dry" AMD. Macular degeneration caused by aging leads to irreversible blindness and loss of vision. According to the National Institute on Aging, up to one third of individuals aged 75 and older have AMD. Researchers would surely benefit from genome-wide association studies in order to enhance their understanding of the genetics of complex diseases including AMD and to develop targeted treatments to prevent or treat it. Obtaining valuable information on epigenetic regulation of AMD will require further research.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Dry Age-Related Macular Degeneration Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Dry Age-Related Macular Degeneration Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.